基于网络药理学探讨熟地黄治疗溃疡性结肠炎的作用机制
Discussion on the Mechanism of Action of Radix Rehmanniae Praeparata in Treating Ulcerative Colitis Using Network Pharmacology
摘要: 目的:利用网络药理学研究策略,结合中药对机体代谢的调控作用,探讨熟地黄防治溃疡性结肠炎的直接作用及间接调控机制。方法:通过网络数据库,筛选得到熟地黄中活性成分可直接作用的病理靶点,构建“活性成分–蛋白靶点–病理机制”直接交互网络;同时,从中药影响内源性物质代谢的角度,筛选出熟地黄参与代谢调控的通路及相关代谢酶。利用分子对接模拟实验,验证所筛选关键靶蛋白与熟地黄中有效成分的结合活性。结果:从数据库中共筛选得到熟地黄中20个潜在活性成分和25个核心靶点,主要涉及细胞表面离子通道等信号通路;分子对接及代谢通路富集分析显示,所筛选关键靶蛋白与熟地黄中有效成分具有良好的结合活性,熟地黄对脂质代谢具有调控作用,亦可作为防治溃疡性结肠炎的间接调控机制。结论:熟地黄防治溃疡性结肠炎有多成分、多靶点、多效性的作用特点,并可能通过调控机体代谢进而发挥防治功效。本研究为后续道地药材资源的开发、熟地黄防治溃疡性结肠炎的药效物质基础及作用机制研究提供了理论支撑。
Abstract: Objective: To explore the direct and indirect mechanisms of Radix Rehmanniae Praeparata (RRP) in preventing and treating ulcerative colitis by using the research strategy of network pharmacology, and by combining with the metabolic regulation of traditional Chinese medicines. Methods: Through the network database, we screened the pathological targets of the active ingredients in RRP, and constructed a direct interaction network of “active ingredient-protein target-pathological mechanism”. Meanwhile, we analyzed its metabolic regulation by evaluating the effects on endogenous substance metabolism. Additionally, endogenous substances and related metabolic enzymes involved in its regulatory effects were screened. The molecular docking simulation experiment was used to verify the binding activities of the screened target proteins with the active ingredients. Results: A total of 20 potential active ingredients and 25 core targets were identified from the database, which were mainly involved in cell surface ion channels and other signaling pathways; the molecular docking results and metabolic pathway enrichment analyses showed that the screened key target proteins had good binding activities with the active ingredients in RRP, and RRP had a regulatory effect on lipid metabolism. It can also be used as an indirect regulatory mechanism to prevent ulcerative colitis. Conclusion: The prevention and treatment of ulcerative colitis by RRP is characterized by multi-components, multi-targets, wide range of efficacy outputs, and it may exert preventive and curative effects through the modulation of organismal metabolism. The present study provides theoretical support for the development of local medicinal resources and the study of the pharmacological basis and mechanism of action of RRP in the prevention and treatment of ulcerative colitis.
文章引用:杨玉叶, 赵芮可, 魏召巍, 高一乔. 基于网络药理学探讨熟地黄治疗溃疡性结肠炎的作用机制[J]. 中医学, 2025, 14(8): 3592-3602. https://doi.org/10.12677/tcm.2025.148528

参考文献

[1] 柳慧, 张玉洁, 吴开春. 炎症性肠病临床研究现状及进展[J]. 临床内科杂志, 2021, 38(2): 90-93.
[2] Oladele, J.O., Anyim, J.C., Oyeleke, O.M., Olowookere, B.D., Bamigboye, M.O., Oladele, O.T., et al. (2021) Telfairia occidentalis Mitigates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Rats via Suppression of Oxidative Stress, Lipid Peroxidation, and Inflammation. Journal of Food Biochemistry, 45, e13873. [Google Scholar] [CrossRef] [PubMed]
[3] Sinha, A., Li, Y., Mirzaei, M.K., Shamash, M., Samadfam, R., King, I.L., et al. (2022) Transplantation of Bacteriophages from Ulcerative Colitis Patients Shifts the Gut Bacteriome and Exacerbates the Severity of DSS Colitis. Microbiome, 10, Article No. 105. [Google Scholar] [CrossRef] [PubMed]
[4] Boland, B.S., He, Z., Tsai, M.S., Olvera, J.G., Omilusik, K.D., Duong, H.G., et al. (2020) Heterogeneity and Clonal Relationships of Adaptive Immune Cells in Ulcerative Colitis Revealed by Single-Cell Analyses. Science Immunology, 5, eabb4432. [Google Scholar] [CrossRef] [PubMed]
[5] 叶雪珂, 单国顺, 付郁, 等. 溃疡性结肠炎发病机制及中西医治疗的研究进展[J]. 中华中医药学刊, 2022, 40(9): 158-162+281.
[6] Jaber, F., Ayyad, M., Alsakarneh, S., Alsharaeh, T., Salahat, A., Jaber, M., et al. (2024) Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Therapeutics, 32, e17-e29. [Google Scholar] [CrossRef] [PubMed]
[7] Su, S., Liu, T., Zheng, J., Wu, H., Keng, V.W., Zhang, S., et al. (2024) Huang Lian Jie Du Decoction Attenuated Colitis via Suppressing the Macrophage Csf1r/Src Pathway and Modulating Gut Microbiota. Frontiers in Immunology, 15, Article 1375781. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, J., Tan, B., Wu, H., Han, T., Fang, D., Cai, H., et al. (2025) Scutellaria baicalensis Extracts Restrict Intestinal Epithelial Cell Ferroptosis by Regulating Lipid Peroxidation and GPX4/ACSL4 in Colitis. Phytomedicine, 141, Article 156708. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, C., Lin, X., Xie, Y., Xiong, S., Hou, S., Huang, S., et al. (2025) Shengjiang Xiexin Decoction Ameliorates DSS-Induced Ulcerative Colitis via Activating Wnt/β-Catenin Signaling to Enhance Epithelium Renovation and Modulating Intestinal Flora. Phytomedicine, 139, Article 156456. [Google Scholar] [CrossRef] [PubMed]
[10] 刘卫欣, 卢兖伟, 杜海涛, 等. 地黄及其活性成分药理作用研究进展[J]. 国际药学研究杂志, 2009, 36(4): 277-280.
[11] Jeong, S.H., Jang, J.H., Cho, H.Y., et al. (2020) Simultaneous Determination of Three Iridoid Glycosides of Rehmannia glutinosa in Rat Biological Samples Using a Validated Hydrophilic Interaction-UHPLC-MS/MS Method in Pharmacokinetic and in Vitro Studies. Journal of Separation Science, 43, 4148-4161. [Google Scholar] [CrossRef] [PubMed]
[12] 陈新林, 张长荣, 王丹丹, 等. 溃疡性结肠炎证候分布的文献研究[J]. 中华中医药学刊, 2017, 35(2): 378-381.
[13] Hu, Y., Ye, Z., She, Y., Li, L., Wu, M., Qin, K., et al. (2022) Efficacy and Safety of Probiotics Combined with Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 13, Article 844961. [Google Scholar] [CrossRef] [PubMed]
[14] Lv, H., Jia, H., Cai, W., Cao, R., Xue, C. and Dong, N. (2023) Rehmannia glutinosa Polysaccharides Attenuates Colitis via Reshaping Gut Microbiota and Short-Chain Fatty Acid Production. Journal of the Science of Food and Agriculture, 103, 3926-3938. [Google Scholar] [CrossRef] [PubMed]
[15] Zhao, Z.H., Dong, Y.H., Jiang, X.Q., et al. (2024) Five Commonly Used Traditional Chinese Medicine Formulas in the Treatment of Ulcerative Colitis: A Network Meta-Analysis. World Journal of Clinical Cases, 12, 5067-5082. [Google Scholar] [CrossRef] [PubMed]
[16] 张建永, 杨沙, 陈宽, 等. 基于网络药理学的理气活血滴丸治疗心血管疾病作用机制研究[J]. 中药材, 2019, 42(5): 1139-1145.
[17] 唐路梅, 杨玲芳, 唐芳, 等. 基于网络药理学和分子对接技术探讨四君子汤治疗2型糖尿病的作用机制[J]. 国际临床医学, 2024, 6(5): 23-29.
[18] 张晓囡, 张军平, 徐士欣, 等. 基于网络药理学的黄连解毒汤治疗高血压潜在机制研究[J]. 中草药, 2018, 49(24): 5865-5875.
[19] Andersen, C.J. (2022) Lipid Metabolism in Inflammation and Immune Function. Nutrients, 14, Article 1414. [Google Scholar] [CrossRef] [PubMed]
[20] Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P. and Kopecky, J. (2015) Lipid Signaling in Adipose Tissue: Connecting Inflammation & Metabolism. Biochimica et Biophysica ActaMolecular and Cell Biology of Lipids, 1851, 503-518. [Google Scholar] [CrossRef] [PubMed]
[21] 白颖璐, 张金芳, 沙子珺, 等. 基于网络药理学和分子对接分析八味三香散治疗慢性心力衰竭的潜在分子机制[J]. 中国中药杂志, 2021, 46(10): 2392-2402.
[22] 陈泓竹, 刘建明, 周芳, 等. 内源性物质代谢对药物代谢处置的影响及机制研究[J]. 中国临床药理学与治疗学, 2019, 24(5): 580-588.
[23] 叶慧, 郝海平. 内源性代谢物靶标发现及其在精准靶向肿瘤治疗中的应用前景[J]. 医学研究生学报, 2019, 32(5): 468-473.
[24] 盛天骄, 闫思蒙, 兰威儒, 等. 中药对溃疡性结肠炎肠道微生物代谢产物的作用研究进展[J]. 中国中西医结合消化杂志, 2023, 31(11): 903-908.
[25] Li, M., Wu, Y., Qiu, J., et al. (2023) Huangqin Decoction Ameliorates Ulcerative Colitis by Regulating Fatty Acid Metabolism to Mediate Macrophage Polarization via Activating FFAR4-AMPK-PPARα Pathway. Journal of Ethnopharmacology, 311, Article 116430.
[26] Zhang, Y., Zhu, M., Dai, Y., Gao, L. and Cheng, L. (2024) Research Progress in Ulcerative Colitis: The Role of Traditional Chinese Medicine on Gut Microbiota and Signaling Pathways. The American Journal of Chinese Medicine, 52, 2277-2336. [Google Scholar] [CrossRef] [PubMed]
[27] Decara, J., Rivera, P., López-Gambero, A.J., Serrano, A., Pavón, F.J., Baixeras, E., et al. (2020) Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Frontiers in Pharmacology, 11, Article 730. [Google Scholar] [CrossRef] [PubMed]
[28] Yuan, G., Chen, X. and Li, D. (2015) Modulation of Peroxisome Proliferator-Activated Receptor Gamma (PPAR γ) by Conjugated Fatty Acid in Obesity and Inflammatory Bowel Disease. Journal of Agricultural and Food Chemistry, 63, 1883-1895. [Google Scholar] [CrossRef] [PubMed]
[29] Xu, Q., Yao, Y., Liu, Y., Zhang, J. and Mao, L. (2023) The Mechanism of Traditional Medicine in Alleviating Ulcerative Colitis: Regulating Intestinal Barrier Function. Frontiers in Pharmacology, 14, Article 1228969. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, W., You, D., Lin, J., Zou, H., Zhang, L., Luo, S., et al. (2024) SGLT2 Inhibitor Promotes Ketogenesis to Improve MASH by Suppressing CD8+ T Cell Activation. Cell Metabolism, 36, 2245-2261.e6. [Google Scholar] [CrossRef] [PubMed]